ATE196847T1 - Verwendung von mannosephosphaten zur behandlung von fibrotischen störungen - Google Patents
Verwendung von mannosephosphaten zur behandlung von fibrotischen störungenInfo
- Publication number
- ATE196847T1 ATE196847T1 AT93906680T AT93906680T ATE196847T1 AT E196847 T1 ATE196847 T1 AT E196847T1 AT 93906680 T AT93906680 T AT 93906680T AT 93906680 T AT93906680 T AT 93906680T AT E196847 T1 ATE196847 T1 AT E196847T1
- Authority
- AT
- Austria
- Prior art keywords
- pct
- mannose
- fibrotic disorders
- phosphates
- sec
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929205800A GB9205800D0 (en) | 1992-03-17 | 1992-03-17 | Treatment of fibrotic disorders |
PCT/GB1993/000541 WO1993018777A1 (en) | 1992-03-17 | 1993-03-16 | Use of mannose phosphates for the treatment of fibrotic disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE196847T1 true ATE196847T1 (de) | 2000-10-15 |
Family
ID=10712310
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT93906680T ATE196847T1 (de) | 1992-03-17 | 1993-03-16 | Verwendung von mannosephosphaten zur behandlung von fibrotischen störungen |
Country Status (18)
Country | Link |
---|---|
US (1) | US5520926A (de) |
EP (1) | EP0728006B1 (de) |
JP (1) | JP3930556B2 (de) |
AT (1) | ATE196847T1 (de) |
AU (1) | AU667887B2 (de) |
CA (1) | CA2130805C (de) |
DE (1) | DE69329559T2 (de) |
DK (1) | DK0728006T3 (de) |
ES (1) | ES2151903T3 (de) |
GB (2) | GB9205800D0 (de) |
GR (1) | GR3035117T3 (de) |
IL (1) | IL105079A (de) |
NO (1) | NO306808B1 (de) |
NZ (1) | NZ249915A (de) |
PT (1) | PT728006E (de) |
SG (1) | SG49899A1 (de) |
WO (1) | WO1993018777A1 (de) |
ZA (1) | ZA931869B (de) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9106678D0 (en) * | 1991-03-28 | 1991-05-15 | Ferguson Mark W J | Wound healing |
SE9403137D0 (sv) * | 1994-09-20 | 1994-09-20 | Perstorp Ab | Derivatives of carbohydrates and compositions containing them |
GB9516012D0 (en) * | 1995-08-04 | 1995-10-04 | Univ Manchester | Pharmaceutical composition |
US6566339B1 (en) | 1995-08-04 | 2003-05-20 | Renovo Limited | Pharmaceutical composition |
GB2306481A (en) * | 1995-10-21 | 1997-05-07 | Univ Manchester | Pharmaceutical comprising a stimulator of activin and/or inhibin |
US6093388A (en) * | 1996-08-12 | 2000-07-25 | Btg International Limited | Mannose-6-phosphate composition and its use in treating fibrotic disorders |
GB9616896D0 (en) * | 1996-08-12 | 1996-09-25 | British Tech Group | Pharmaceutical compositions |
DE19758059C2 (de) * | 1997-12-29 | 2001-10-04 | Thorsten Marquardt | Verwendung von Mannose zur Bekämpfung der Proteinverlust-Enteropathie |
US7255883B2 (en) * | 2000-06-23 | 2007-08-14 | Healagenics, Inc. | Agent for reduction of scar formation by using wound alkalinization |
EP1345602B1 (de) * | 2000-11-30 | 2010-07-21 | Novodermix International Limited | Heilung von wunden |
US20030031689A1 (en) * | 2001-08-09 | 2003-02-13 | Thomas Mammone | Method of skin exfoliation |
US6822033B2 (en) | 2001-11-19 | 2004-11-23 | United States Gypsum Company | Compositions and methods for treating set gypsum |
JP4564261B2 (ja) * | 2002-01-22 | 2010-10-20 | ジェンザイム、コーポレーション | 慢性的移植片拒絶反応の治療と予防のためのTGF−β拮抗薬の使用 |
RU2308954C2 (ru) * | 2002-05-09 | 2007-10-27 | Медиджинез | Фармацевтическая композиция для лечения ран, содержащая плазму или сыворотку крови |
GB0217136D0 (en) | 2002-07-24 | 2002-09-04 | Renovo Ltd | Wound healing & treatment of fibrosis |
KR100492913B1 (ko) * | 2002-08-23 | 2005-06-03 | 주식회사 태평양 | 피부 감작 및 자극을 완화하는 피부 외용제 조성물 |
US20050136126A1 (en) * | 2003-03-17 | 2005-06-23 | Cambridgemed, Inc. | Agent for reduction of scar formation by using wound alkalinization |
JP4634027B2 (ja) * | 2003-05-16 | 2011-02-16 | 花王株式会社 | ビタミンd様活性代替用剤 |
US7276486B2 (en) * | 2004-03-15 | 2007-10-02 | Kimberly-Clark Worldwide, Inc. | Compositions for vaginal treatment |
AU2005230848B9 (en) * | 2004-03-31 | 2011-06-02 | Genentech, Inc. | Humanized anti-TGF-beta antibodies |
EP1809324A4 (de) * | 2004-10-13 | 2009-02-25 | Univ Ohio State Res Found | Verfahren zur behandlung oder prävention von viralen lymphoproliferativen erkrankungen |
US7323184B2 (en) * | 2005-08-22 | 2008-01-29 | Healagenics, Inc. | Compositions and methods for the treatment of wounds and the reduction of scar formation |
US20070048391A1 (en) * | 2005-08-23 | 2007-03-01 | Cambridgemed, Inc. | Composition for reduction of scar formation on wound scar |
JP5602365B2 (ja) | 2005-10-25 | 2014-10-08 | ザ・ジョンズ・ホプキンス・ユニバーシティ | マルファン症候群及び関連疾患を治療するための方法及び組成物。 |
EP1998810A4 (de) | 2006-03-13 | 2009-09-02 | Univ Johns Hopkins | Erhöhung der endothelialen thromboresistenz |
PL2083863T3 (pl) | 2006-10-03 | 2015-08-31 | Genzyme Corp | Przeciwciała przeciwko TGF-beta do stosowania w leczeniu niemowląt obarczonych ryzykiem rozwinięcia się dysplazji oskrzelowo-płucnej |
US8070895B2 (en) | 2007-02-12 | 2011-12-06 | United States Gypsum Company | Water resistant cementitious article and method for preparing same |
US8329308B2 (en) | 2009-03-31 | 2012-12-11 | United States Gypsum Company | Cementitious article and method for preparing the same |
GB0910078D0 (en) * | 2009-06-11 | 2009-07-22 | Renovo Ltd | Uses of mannose-6-phosphate |
GB0916333D0 (en) | 2009-09-17 | 2009-10-28 | Renovo Ltd | Improvement of tendon repair |
GB0916334D0 (en) * | 2009-09-17 | 2009-10-28 | Renovo Ltd | Inhibition of tendon adhesions |
EP3117709B1 (de) | 2010-03-12 | 2018-08-01 | Genzyme Corporation | Kombinationstherapie zur behandlung von brustkrebs |
US20140170236A1 (en) * | 2010-11-05 | 2014-06-19 | Priscilla Hayes Petty | Use of phosphoric acid |
WO2012090997A1 (ja) | 2010-12-27 | 2012-07-05 | 京都府公立大学法人 | iPS細胞とその製造法 |
EP2737083A1 (de) | 2011-07-27 | 2014-06-04 | INSERM (Institut National de la Santé et de la Recherche Scientifique) | Verfahren zur diagnose und behandlung des myhre-syndroms |
CA2853484C (en) | 2011-10-26 | 2018-08-21 | Seattle Children's Research Institute | Cysteamine in the treatment of fibrotic disease |
EP2799537B1 (de) | 2011-12-28 | 2021-09-22 | Kyoto Prefectural Public University Corporation | Normalisierung der züchtung von hornhautendothelzellen |
EP3804760A1 (de) | 2013-10-31 | 2021-04-14 | Kyoto Prefectural Public University Corporation | Therapeutikum für erkrankungen im zusammenhang mit endoplasmatischem retikulumszelltod im hornhautendothel |
US10882903B2 (en) | 2015-05-18 | 2021-01-05 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Methods and compositions for treating an alphavirus infection |
WO2023172636A1 (en) * | 2022-03-08 | 2023-09-14 | University Of Mississippi Medical Center | Articles and methods for improved tissue healing |
CN115260256A (zh) * | 2022-07-22 | 2022-11-01 | 河南中医药大学 | 一种甘露糖磷酸化衍生物及其制备方法和应用 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE756953A (fr) * | 1969-10-02 | 1971-04-01 | Merck & Co Inc | Potentialisation d'antibiotiques |
JPS5631156B2 (de) * | 1973-09-25 | 1981-07-20 | ||
IT1170618B (it) * | 1981-01-13 | 1987-06-03 | Foscama Biomed Chim Farma | Preparato farmacologico di frutto sio-1,6-difosfato ad azione terapeutica nei pazienti ustionati |
US4703040A (en) * | 1985-04-03 | 1987-10-27 | Markov Angel K | Treatment of adult respiratory distress syndrome (ARDS) using fructose diphosphate (FDP) |
US4889844A (en) * | 1985-10-22 | 1989-12-26 | Silvetti Sr Anthony N | Fructose containing wound healing preparation |
EP0221728B1 (de) * | 1985-10-22 | 1992-07-15 | Anthony N. Silvetti, Sr. | Monosaccharide enthaltende Zusammensetzung zum Heilen von Wunden |
AU607690B2 (en) * | 1985-12-24 | 1991-03-14 | Marion Laboratories, Inc. | Use of synthetic sulfated saccharides to enhance wound healing |
JPS62243675A (ja) * | 1986-04-15 | 1987-10-24 | Kao Corp | pH緩衝法 |
WO1990001938A1 (en) * | 1988-08-19 | 1990-03-08 | The Australian National University | Phosphosugar-based anti-inflammatory and/or immunosuppressive drugs |
GB8917414D0 (en) * | 1989-07-29 | 1989-09-13 | Translift Material Handling | Narrow aisle lift truck |
CA2065860C (en) * | 1989-09-29 | 2001-03-27 | Wayne A. Border | Inhibiting transforming growth factor .beta. to prevent accumulation of extracellular matrix |
SE8904354D0 (sv) * | 1989-12-21 | 1989-12-21 | Matti Siren | A pharmaceutical composition |
GB9106678D0 (en) * | 1991-03-28 | 1991-05-15 | Ferguson Mark W J | Wound healing |
JPH0558868A (ja) * | 1991-08-27 | 1993-03-09 | Kao Corp | 親水性紫外線吸収剤及びこれを含有する化粧料 |
AU3943793A (en) * | 1992-04-01 | 1993-11-08 | Whittier Institute For Diabetes And Endocrinology, The | Methods of inhibiting or enhancing scar formation in the CNS |
JPH09155319A (ja) * | 1995-12-13 | 1997-06-17 | Takeo Tsutsui | 重金属含有焼却灰等、シュレッダーダストの無公害化処理方法および再利用材の製造方法 |
-
1992
- 1992-03-17 GB GB929205800A patent/GB9205800D0/en active Pending
-
1993
- 1993-03-16 DE DE69329559T patent/DE69329559T2/de not_active Expired - Lifetime
- 1993-03-16 NZ NZ249915A patent/NZ249915A/en not_active IP Right Cessation
- 1993-03-16 EP EP93906680A patent/EP0728006B1/de not_active Expired - Lifetime
- 1993-03-16 PT PT93906680T patent/PT728006E/pt unknown
- 1993-03-16 US US08/290,939 patent/US5520926A/en not_active Expired - Lifetime
- 1993-03-16 JP JP51635793A patent/JP3930556B2/ja not_active Expired - Lifetime
- 1993-03-16 DK DK93906680T patent/DK0728006T3/da active
- 1993-03-16 GB GB9305344A patent/GB2265310B/en not_active Expired - Lifetime
- 1993-03-16 ZA ZA931869A patent/ZA931869B/xx unknown
- 1993-03-16 WO PCT/GB1993/000541 patent/WO1993018777A1/en active IP Right Grant
- 1993-03-16 AT AT93906680T patent/ATE196847T1/de active
- 1993-03-16 AU AU37590/93A patent/AU667887B2/en not_active Expired
- 1993-03-16 IL IL105079A patent/IL105079A/en not_active IP Right Cessation
- 1993-03-16 SG SG1996008660A patent/SG49899A1/en unknown
- 1993-03-16 CA CA002130805A patent/CA2130805C/en not_active Expired - Lifetime
- 1993-03-16 ES ES93906680T patent/ES2151903T3/es not_active Expired - Lifetime
-
1994
- 1994-09-16 NO NO943451A patent/NO306808B1/no not_active IP Right Cessation
-
2000
- 2000-12-19 GR GR20000402805T patent/GR3035117T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
NO943451D0 (no) | 1994-09-16 |
GB2265310B (en) | 1996-09-25 |
GB2265310A (en) | 1993-09-29 |
WO1993018777A1 (en) | 1993-09-30 |
NO943451L (no) | 1994-09-16 |
GB9205800D0 (en) | 1992-04-29 |
GR3035117T3 (en) | 2001-03-30 |
JP3930556B2 (ja) | 2007-06-13 |
CA2130805C (en) | 2003-06-24 |
IL105079A (en) | 1998-06-15 |
ZA931869B (en) | 1994-09-16 |
DE69329559T2 (de) | 2001-05-31 |
AU667887B2 (en) | 1996-04-18 |
ES2151903T3 (es) | 2001-01-16 |
DE69329559D1 (de) | 2000-11-16 |
GB9305344D0 (en) | 1993-05-05 |
EP0728006A1 (de) | 1996-08-28 |
IL105079A0 (en) | 1993-07-08 |
US5520926A (en) | 1996-05-28 |
SG49899A1 (en) | 1998-06-15 |
CA2130805A1 (en) | 1993-09-30 |
NZ249915A (en) | 1996-08-27 |
JPH07504909A (ja) | 1995-06-01 |
DK0728006T3 (da) | 2000-10-30 |
PT728006E (pt) | 2001-04-30 |
NO306808B1 (no) | 1999-12-27 |
EP0728006B1 (de) | 2000-10-11 |
AU3759093A (en) | 1993-10-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE196847T1 (de) | Verwendung von mannosephosphaten zur behandlung von fibrotischen störungen | |
ATE164067T1 (de) | Verwendung von riluzole zur behandlung von traumatischen neurologischen-schädigungen | |
DE69733132D1 (de) | Verwendung von antioxidantien zur behandlung cholestatischer lebererkrankungen | |
RU94031102A (ru) | Сульфамиды в качестве антагонистов эндотелина и способ лечения соответствующих заболеваний | |
DE69526937D1 (de) | Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen | |
ATE207356T1 (de) | Verwendung von tiagabin zur behandlung von schlafstörungen | |
DE59409832D1 (de) | Pflaster zur behandlung von nagelmykosen | |
ATE154758T1 (de) | Levobupivacain nützlich zur behandlung von chronischen schmerzen | |
ATE258796T1 (de) | Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen | |
ATE321548T1 (de) | Verwendung von statin zur behandlung von hauterkrankungen | |
ATE214272T1 (de) | Topische verwendung von kappa- opioidrezeptoragonisten zur behandlung von augenschmerz | |
ATE251631T1 (de) | Dipohosphonsäuresalze für die behandlung von osteoporose | |
DE59902666D1 (de) | Edelfosin zur behandlung von hirntumoren | |
DE69818809D1 (de) | Verfahren zur behandlung von narbengewebe | |
ATE275964T1 (de) | Verwendung von betalycan zur verminderung der narbenbildung | |
ATE236633T1 (de) | Topische verwendung von loperamid zur behandlung mikrobieller infektionen | |
DE69124382T3 (de) | Authentischen igf-1 und hypokalorische menge von nährstoffen enthaltendes produkt und dessen verwendung zur behandlung kataboler zustände | |
DE59410340D1 (de) | Verwendung von Bradykinin-Antagonisten zur Behandlung von Viruserkrankungen | |
DE69732851D1 (de) | Verwendung von dextrinsulfat zur behandlung von sehr vasculären tumoren | |
DE69832796D1 (de) | Verwendung von mizolastine zur herstellung eines arzneimittels zur behandlung von entzündungen | |
ATE150645T1 (de) | Verwendung von bmy 14802 zur behandlung von angstzuständen bei patienten mit benzodiazepin- entzugserscheinungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |